Hendra virus

Hendra virus
Name	Hendra virus
Familia	Paramyxoviridae
Genus	Henipavirus
Species	Hendra henipavirus

Hendra virus is a zoonotic paramyxovirus first identified after an outbreak in 1994 in Brisbane, Queensland, Australia. The virus causes severe respiratory and neurological disease in horses and humans and is genetically related to other henipaviruses discovered in Asia and Australia. Outbreaks have prompted responses from veterinary services, research institutes, public health agencies, and One Health collaborations across Australia and internationally.

Virology and Classification

Hendra virus is a member of the family Paramyxoviridae and the genus Henipavirus, alongside related agents such as Nipah virus. The virion is enveloped and contains a negative-sense, single-stranded RNA genome encoding nucleoprotein, phosphoprotein, matrix protein, fusion protein, attachment glycoprotein, and polymerase. Structural and functional studies involving groups at institutions like the Commonwealth Scientific and Industrial Research Organisation and the Peter Doherty Institute for Infection and Immunity have elucidated the roles of the fusion (F) and attachment (G) glycoproteins in host cell entry, with ephrin-B2 and ephrin-B3 identified as cellular receptors. Comparative genomics and phylogenetic analyses using sequence data deposited in databases coordinated by organizations including the World Health Organization and the CSL Limited have informed taxonomic placement within Paramyxoviridae.

Reservoirs and Transmission

Fruit bats (flying foxes) of the genus Pteropus are the principal natural reservoirs, with field studies conducted in regions such as Queensland, New South Wales, and the Northern Territory documenting viral RNA and seropositivity in populations. Spillover to intermediate hosts, most commonly horses, is thought to occur via contamination of feed or pasture with bat excreta, saliva, or birthing products; investigations by veterinary services, universities like the University of Sydney, and government agencies have supported these transmission pathways. Human infection has occurred through close contact with infected horses during veterinary procedures, necropsy, or caregiving, leading to occupational health concerns addressed by regulatory bodies such as the Australian Veterinary Association and workplace safety regulators. Research collaborations including the Australian Centre for Disease Preparedness and international partners have explored environmental, ecological, and anthropogenic factors that influence spillover risk, including urban expansion, habitat loss, and climatic events like El Niño–Southern Oscillation episodes.

Clinical Presentation and Pathogenesis

In horses, infection can produce acute febrile illness, respiratory distress, and neurological signs; outbreaks have led to rapid deterioration and euthanasia to prevent onward transmission, with case investigations conducted by state veterinary authorities. In humans, clinical manifestations range from influenza-like symptoms to severe pneumonia, acute respiratory distress syndrome, and encephalitis; case series reported by hospitals, coronial inquiries, and public health agencies have documented delayed-onset encephalitic relapse in some survivors. Pathogenesis involves viral replication in respiratory epithelium and endothelial cells, systemic vasculitis, and immune-mediated tissue injury; pathology studies published by researchers affiliated with institutions like the University of Melbourne and the CSL Research laboratories have characterized widespread vascular involvement and central nervous system tropism. Fatality rates in reported human cases have been high, prompting inclusion of Hendra infection in notifiable disease lists managed by state health departments and the Department of Health and Aged Care (Australia).

Diagnosis and Laboratory Testing

Diagnostic approaches include molecular assays such as reverse transcription polymerase chain reaction performed in high-containment laboratories like those certified at the Australian Centre for Disease Preparedness, serological tests including enzyme-linked immunosorbent assays, and virus isolation under biosafety level 4 conditions. Case confirmation typically requires coordination between local hospitals, public health laboratories, veterinary diagnostic services, and reference centers to ensure appropriate specimen handling and biosafety; protocols have been developed by agencies including the Public Health Laboratory Network and state pathology services. Imaging modalities used in clinical assessment have involved intensive care units at tertiary hospitals such as Royal Brisbane and Women's Hospital and neuroradiology teams in referral centers. Laboratory surveillance and genomic sequencing efforts have been supported by national research infrastructures and collaborations with international partners like the Centers for Disease Control and Prevention.

Treatment and Prevention

There is no licensed antiviral therapy specific to Hendra virus; supportive care in intensive care units, including respiratory support and management of encephalitis, constitutes primary clinical treatment, delivered by multidisciplinary teams at major hospitals. A monoclonal antibody (m102.4) developed through partnerships involving organizations such as the Commonwealth Scientific and Industrial Research Organisation and deployed on a compassionate basis has been used in exposed individuals under investigational protocols. Prevention in equine populations has been advanced by a commercially available subunit vaccine for horses produced by CSL Limited, which has reduced spillover events when widely adopted alongside risk mitigation practices promoted by the Australian Veterinary Association and state biosecurity agencies. Public health measures encompass personal protective equipment guidance from workplace safety regulators, infection control policies in hospitals like Royal Prince Alfred Hospital, and One Health surveillance frameworks integrating wildlife ecologists, veterinarians, and public health officials.

Epidemiology and Public Health Response

Since its emergence in 1994, episodic spillover events have occurred primarily in eastern Australia, with investigations led by state chief veterinary officers, the Department of Agriculture, Fisheries and Forestry (Australia), and public health departments assessing risk, implementing quarantines, and advising on vaccination and biosecurity. Outbreak responses have included euthanasia of infected animals, movement controls, and public communication campaigns coordinated with media outlets and agencies such as the Australian Broadcasting Corporation to inform affected communities. Internationally, Hendra virus has influenced preparedness planning by organizations like the World Health Organization and the Food and Agriculture Organization for zoonotic paramyxoviruses, and spurred research collaborations across universities, government laboratories, and the private sector to develop countermeasures, diagnostics, and surveillance systems. Continued surveillance of Pteropus populations, vaccine uptake monitoring, and integration of ecological data into public health decision-making remain central to reducing future spillover risk.

Category:Paramyxoviridae Category:Zoonoses Category:Infectious disease